MG
CNS icon

Michael Gelband’s Cohen & Steers CNS Stock Holding History

Michael Gelband’s Portfolio CNS Stock Details CNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Buy
+26,670
New +$1.89M 0.01% 812
2026
Q1 		– Sell
-29,469
Closed -$1.85M – 1627
2025
Q4 		$1.85M Sell
29,469
-13,120
-31% -$853K 0.01% 801
2025
Q3 		$2.79M Buy
42,589
+22,818
+115% +$1.67M 0.03% 615
2025
Q2 		$1.49M Sell
19,771
-905
-4% -$69.6K 0.01% 842
2025
Q1 		$1.66M Sell
20,676
-13,750
-40% -$1.17M 0.02% 759
2024
Q4 		$3.18M Buy
34,426
+27,332
+385% +$2.7M 0.02% 565
2024
Q3 		$681K Sell
7,094
-1,798
-20% -$153K ﹤0.01% 1091
2024
Q2 		$645K Sell
8,892
-6,653
-43% -$473K ﹤0.01% 1158
2024
Q1 		$1.2M Buy
+15,545
New +$1.11M 0.01% 882
2023
Q4 		– Sell
-5,970
Closed -$374K – 1548
2023
Q3 		$374K Sell
5,970
-5,049
-46% -$319K ﹤0.01% 1338
2023
Q2 		$639K Sell
11,019
-18,548
-63% -$1.08M 0.01% 1272
2023
Q1 		$1.89M Buy
29,567
+12,463
+73% +$869K 0.02% 905
2022
Q4 		$1.1M Buy
17,104
+11,572
+209% +$726K 0.02% 897
2022
Q3 		$346K Buy
+5,532
New +$396K ﹤0.01% 1482
2022
Q2 		– Sell
-12,452
Closed -$1.07M – 2003
2022
Q1 		$1.07M Buy
12,452
+7,635
+159% +$632K 0.01% 1103
2021
Q4 		$446K Sell
4,817
-4,475
-48% -$414K ﹤0.01% 1481
2021
Q3 		$778K Buy
9,292
+3,861
+71% +$327K 0.01% 1151
2021
Q2 		$446K Sell
5,431
-6,173
-53% -$445K ﹤0.01% 1517
2021
Q1 		$758K Buy
11,604
+871
+8% +$59.5K 0.01% 1088
2020
Q4 		$797K Sell
10,733
-1,333
-11% -$87.9K 0.01% 981
2020
Q3 		$673K Sell
12,066
-3,722
-24% -$230K 0.01% 863
2020
Q2 		$1.07M Buy
+15,788
New +$952K 0.03% 711
2019
Q3 		– Sell
-6,384
Closed -$328K – 1367
2019
Q2 		$328K Buy
+6,384
New +$313K 0.01% 652

Other funds holding CNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Michael Gelband's CNS Position: Q2 2026 in Review

Michael Gelband opened a new position in Cohen & Steers (CNS) in Q2 2026: 26,670 shares worth $2.03M. The stake represents 0.01% of the portfolio and ranks #812 among its holdings. This is a return to the name: Michael Gelband previously reported a position in CNS as recently as Q4 2025.

Michael Gelband first reported a position in CNS in Q2 2019 and has held it in 23 quarters since. The position peaked at $3.18M in Q4 2024. 310 funds tracked by Wall St. Rank hold CNS as of Q2 2026.

  • Michael Gelband held 26,670 shares of Cohen & Steers worth $2.03M as of Q2 2026.
  • Cohen & Steers was a new Michael Gelband position in Q2 2026.
  • Cohen & Steers made up 0.01% of Michael Gelband's portfolio in Q2 2026, its #812 holding.
  • Michael Gelband first reported a position in Cohen & Steers in Q2 2019 and has held it in 23 quarters since.
  • Michael Gelband's Cohen & Steers position peaked at $3.18M in Q4 2024.
  • 310 funds tracked by Wall St. Rank held Cohen & Steers as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.